StockData
Lifecore Biomedical, Inc. logo

Lifecore Biomedical, Inc. (LFCR) bonds

LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
Số liệu tài chính tới Q4 năm tài chính 2025, quý kết thúc ngày May 25, 2025Last filing: 10-Q on Nov 4, 2026Score 4/30
$6.39−0.03 (-0.39%)

Close on Nov 17, 2026Market cap $241.88MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Lifecore Biomedical reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Lifecore Biomedical's 10-Q for the period ended Jun 30, 2026

IssueCouponAmount issuedCarrying value
Finance lease liability––$5.79M
Leaseback liability with related party––$5.41M
Revolving credit facility––$0
Term Loan Credit Agreement3.00%$142.27M–
Term loan credit facility with related party10.00%–$192.73M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySize
Revolving Credit Agreement$40.00M
Revolving Credit Agreement, FILO Tranche$2.50M

See a number that looks wrong?